<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epithelial-mesenchymal transition (EMT) is a morphogenetic process characterized by the acquisition of mesenchymal properties linked with an invasive phenotype and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>NK group 2, member D (NKG2D) is an NK cell-activating receptor crucially involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> immunosurveillance </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we show that induction of EMT by TGF-β stimulation of human keratinocytes, by <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3β inhibition in several <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumor</z:e> cell lines, and by Snail1 overexpression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells strongly upregulated the expression of NKG2D ligands (NKG2DLs), MHC class I chain-related molecules A and B (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B) and ULBP1-3 </plain></SENT>
<SENT sid="3" pm="."><plain>Overexpression of Snail1 and inhibition of <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3β in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cells markedly induced the activity of Sp1 transcription factor, which plays a key role in the upregulation of NKG2DL expression during EMT </plain></SENT>
<SENT sid="4" pm="."><plain>The stimulation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B expression by TGF-β treatment was independent of Sp1, but it involved posttranslational mechanisms mediated by mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> pathway </plain></SENT>
<SENT sid="5" pm="."><plain>Accordingly, with the increased expression of NKG2DLs, triggering of EMT rendered <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells more susceptible to NKG2D-mediated killing by NK cells </plain></SENT>
<SENT sid="6" pm="."><plain>In agreement, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B were expressed in vivo in well-differentiated <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> with retained epithelial characteristics, whereas no expression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B was detected in poorly differentiated and invasive <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> that have lost epithelial characteristics </plain></SENT>
<SENT sid="7" pm="."><plain>This decrease of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B expression was associated with a dramatic increase of NKG2D(+)-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> infiltrating lymphocytes </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, our findings indicate that EMT is a relevant checkpoint in the control of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> through NKG2D-mediated immune responses </plain></SENT>
</text></document>